TMDX Stock: TransMedics Group, Inc. Stock Price, Analysis & Insights
Get live TMDX stock price $75.95, comprehensive TransMedics Group, Inc. stock analysis, charts, news, and expert forecast. Real-time TMDX stock data and investment insights.
Loading chart data...
TransMedics Group, Inc. (TMDX) Overview
TransMedics Group, Inc. (TMDX) is a publicly traded company in the Healthcare sector , specifically within the Medical - Devices industry . As of the latest trading session, TMDX trades at $75.95 with a market capitalization of 2.63B . Over the past 52 weeks, TMDX has traded between $60.10 and $156.00 , with the current price positioned at approximately 17% of this range . The stock currently t...
Key Takeaways
- Operates in the Healthcare sector (Medical - Devices)
- Market cap: 2.63B
- Current price: $75.95
- 52-week range: $60.10 - $156.00
- P/E ratio: 17.38
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is...
Company Information
- CEO
- Waleed H. Hassanein
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 728
Contact Information
- Website
- https://www.transmedics.com
- Address
- 200 Minuteman Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 17.4)
✓ Higher growth potential with elevated volatility (Beta: 1.88)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for TransMedics Group, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for TransMedics Group, Inc.
- ⚠Investors should consider how TransMedics Group, Inc. fits within their overall portfolio allocation
Market Cap
2.63B
P/E Ratio (TTM)
17.38
Beta
1.88
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare TMDX with peer companies:
- Price
- $54.65
- Market cap
- 4.50B
- Price
- $55.50
- Market cap
- 8.45B
- Price
- $122.63
- Market cap
- 7.20B
- Price
- $63.99
- Market cap
- 4.95B
- Price
- $31.51
- Market cap
- 6.47B
- Price
- $38.17
- Market cap
- 4.76B
- Price
- $76.60
- Market cap
- 6.30B
- Price
- $29.95
- Market cap
- 3.50B
- Price
- $21.66
- Market cap
- 3.40B
- Price
- $28.56
- Market cap
- 7.40B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.